Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2012

Open Access 01-12-2012 | Case report

Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature

Authors: Isidoro Di Carlo, Maurizio Mannino, Adriana Toro, Annalisa Ardiri, Antonio Galia, Giovanni Cappello, Gaetano Bertino

Published in: World Journal of Surgical Oncology | Issue 1/2012

Login to get access

Abstract

Introduction

Alpha-fetoprotein (AFP) is an oncofetal protein produced by hepatocellular carcinoma (HCC). AFP level can also be elevated in other neoplastic or non-neoplastic conditions. An elevated AFP level has high diagnostic significance for HCC; at a level of >200 ng/mL, the probability of HCC is >90%. The aim of the present paper is to report a patient who underwent curative resection of HCC, who had a persistently elevated AFP level postoperatively but did not develop recurrence during a 2-year follow-up period. A review of the literature is also presented.

Case report

An 82-year-old male was referred following a computed tomography scan showing a 160 mm diameter mass in the left lobe of the liver. This huge mass was diagnosed as HCC, arising in the absence of cirrhosis or viral hepatitis. After tumor removal, the patient’s high AFP level persisted for 2 years.

Conclusion

As steatosis was the only pathological change in the remnant liver, this may have caused the persistently elevated AFP level in this patient.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH: Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma. Br J Cancer. 1995, 72: 442-446. 10.1038/bjc.1995.352.PubMedCentralCrossRefPubMed Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH: Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma. Br J Cancer. 1995, 72: 442-446. 10.1038/bjc.1995.352.PubMedCentralCrossRefPubMed
2.
go back to reference Lang H, Sotiropoulos GC, Dömland M, Frühauf NR, Paul A, Hüsing J, Malagò M, Broelsch CE: Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br J Surg. 2005, 92: 198-202. 10.1002/bjs.4763.CrossRefPubMed Lang H, Sotiropoulos GC, Dömland M, Frühauf NR, Paul A, Hüsing J, Malagò M, Broelsch CE: Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br J Surg. 2005, 92: 198-202. 10.1002/bjs.4763.CrossRefPubMed
3.
go back to reference Lubrano J, Huet E, Tsilividis B, François A, Goria O, Riachi G, Scottè M: Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse. World J Surg. 2008, 32: 104-109. 10.1007/s00268-007-9291-0.CrossRefPubMed Lubrano J, Huet E, Tsilividis B, François A, Goria O, Riachi G, Scottè M: Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse. World J Surg. 2008, 32: 104-109. 10.1007/s00268-007-9291-0.CrossRefPubMed
4.
go back to reference Yokoi Y, Suzuki S, Baba SK, Inaba K, Konno H, Nakamura S: Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection. J Gastroenterol. 2005, 40: 274-282. 10.1007/s00535-004-1536-1.CrossRefPubMed Yokoi Y, Suzuki S, Baba SK, Inaba K, Konno H, Nakamura S: Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection. J Gastroenterol. 2005, 40: 274-282. 10.1007/s00535-004-1536-1.CrossRefPubMed
5.
go back to reference Hao K, Luk JM, Lee NP, Mao M, Zhang C, Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC, Poon RT: Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer. 2009, 9: 389-10.1186/1471-2407-9-389.PubMedCentralCrossRefPubMed Hao K, Luk JM, Lee NP, Mao M, Zhang C, Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC, Poon RT: Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer. 2009, 9: 389-10.1186/1471-2407-9-389.PubMedCentralCrossRefPubMed
6.
go back to reference Bosch FX, Ribes J, Borras J: Epidemiology of primary liver cancer. Semin Liver Dis. 1999, 19: 271-285. 10.1055/s-2007-1007117.CrossRefPubMed Bosch FX, Ribes J, Borras J: Epidemiology of primary liver cancer. Semin Liver Dis. 1999, 19: 271-285. 10.1055/s-2007-1007117.CrossRefPubMed
7.
go back to reference Kim JH, Choi MS, Lee H, Kim do Y, Lee JH, Koh KC, Yoo BC, Paik SW, Rhee JC: Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol. 2006, 21: 588-594. 10.1111/j.1440-1746.2005.04127.x.CrossRefPubMed Kim JH, Choi MS, Lee H, Kim do Y, Lee JH, Koh KC, Yoo BC, Paik SW, Rhee JC: Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol. 2006, 21: 588-594. 10.1111/j.1440-1746.2005.04127.x.CrossRefPubMed
8.
go back to reference Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT: Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg. 2008, 207: 20-29. 10.1016/j.jamcollsurg.2008.01.020.CrossRefPubMed Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT: Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg. 2008, 207: 20-29. 10.1016/j.jamcollsurg.2008.01.020.CrossRefPubMed
9.
10.
go back to reference Sherman M: Current status of alpha-fetoprotein testing. Gastroenterol Hepatol (NY). 2011, 7: 113-114. Sherman M: Current status of alpha-fetoprotein testing. Gastroenterol Hepatol (NY). 2011, 7: 113-114.
11.
go back to reference Arrieta O, Cacho B, Morales-Espinosa D, Ruelas Villavicencio A, Flores-Estrada D, Hernàndez-Pedro N: The progressive elevation of alpha-fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer. 2007, 7: 28-10.1186/1471-2407-7-28.PubMedCentralCrossRefPubMed Arrieta O, Cacho B, Morales-Espinosa D, Ruelas Villavicencio A, Flores-Estrada D, Hernàndez-Pedro N: The progressive elevation of alpha-fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer. 2007, 7: 28-10.1186/1471-2407-7-28.PubMedCentralCrossRefPubMed
12.
go back to reference Gervain J: Symptoms of hepatocellular carcinoma. Laboratory tests used for its diagnosis and screening. Orv Hetil. 2010, 151: 1415-1417. 10.1556/OH.2010.28945.CrossRefPubMed Gervain J: Symptoms of hepatocellular carcinoma. Laboratory tests used for its diagnosis and screening. Orv Hetil. 2010, 151: 1415-1417. 10.1556/OH.2010.28945.CrossRefPubMed
13.
go back to reference Lau WY, Lai EC: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreas Dis Int. 2008, 7: 237-757. Lau WY, Lai EC: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreas Dis Int. 2008, 7: 237-757.
14.
go back to reference Shirabe K, Takenaka K, Gion T, Shimada M, Fujiwara Y, Sugimachi K: Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection. J Surg Oncol. 1997, 64: 143-146. 10.1002/(SICI)1096-9098(199702)64:2<143::AID-JSO10>3.0.CO;2-7.CrossRefPubMed Shirabe K, Takenaka K, Gion T, Shimada M, Fujiwara Y, Sugimachi K: Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection. J Surg Oncol. 1997, 64: 143-146. 10.1002/(SICI)1096-9098(199702)64:2<143::AID-JSO10>3.0.CO;2-7.CrossRefPubMed
15.
go back to reference Zhou YM, Yang JM, Li B, Yin ZF, Xu F, Wang B, Xu W, Kan T: Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreas Dis Int. 2010, 9: 33-37. Zhou YM, Yang JM, Li B, Yin ZF, Xu F, Wang B, Xu W, Kan T: Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreas Dis Int. 2010, 9: 33-37.
16.
go back to reference Eleftheriou N, Heathcote J, Thomas HC, Sherlock S: Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma. J Clin Pathol. 1977, 30: 704-708. 10.1136/jcp.30.8.704.PubMedCentralCrossRefPubMed Eleftheriou N, Heathcote J, Thomas HC, Sherlock S: Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma. J Clin Pathol. 1977, 30: 704-708. 10.1136/jcp.30.8.704.PubMedCentralCrossRefPubMed
17.
go back to reference Van der Veek PP, de Vos Tot Nederveen Cappel WH, Langers AM, van Hoek B: Two patients with extremely elevated tumor markers: where is the malignancy?. Gastroenterol Res Pract. 2011, 123743: - Van der Veek PP, de Vos Tot Nederveen Cappel WH, Langers AM, van Hoek B: Two patients with extremely elevated tumor markers: where is the malignancy?. Gastroenterol Res Pract. 2011, 123743: -
18.
go back to reference Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Bernardi M, Trevisani F: Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?. Am J Gastroenterol. 2006, 101: 524-532. 10.1111/j.1572-0241.2006.00443.x.CrossRefPubMed Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Bernardi M, Trevisani F: Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?. Am J Gastroenterol. 2006, 101: 524-532. 10.1111/j.1572-0241.2006.00443.x.CrossRefPubMed
19.
go back to reference Yao DF, Dong ZZ, Yao M: Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreas Dis Int. 2007, 6: 241-247. Yao DF, Dong ZZ, Yao M: Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreas Dis Int. 2007, 6: 241-247.
20.
go back to reference Chan SL, Chan AT, Yeo W: Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?. Future Oncol. 2009, 5: 889-899. 10.2217/fon.09.64.CrossRefPubMed Chan SL, Chan AT, Yeo W: Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?. Future Oncol. 2009, 5: 889-899. 10.2217/fon.09.64.CrossRefPubMed
21.
go back to reference Hsieh CB, Chen TW, Chu CM, Chu HC, Yu CP, Chung KP: Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?. World J Gatroenterol. 2010, 16: 3049-3055. 10.3748/wjg.v16.i24.3049.CrossRef Hsieh CB, Chen TW, Chu CM, Chu HC, Yu CP, Chung KP: Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?. World J Gatroenterol. 2010, 16: 3049-3055. 10.3748/wjg.v16.i24.3049.CrossRef
22.
go back to reference Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, Coderc E, Reboullet P, Beaugrand M: Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 1994, 20: 65-71. 10.1016/S0168-8278(05)80468-4.CrossRefPubMed Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, Coderc E, Reboullet P, Beaugrand M: Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 1994, 20: 65-71. 10.1016/S0168-8278(05)80468-4.CrossRefPubMed
23.
go back to reference Chang CH, Chau GY, Lui WY, Tsay Sh, King KL, Wu CW: Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg. 2004, 139: 320-325. 10.1001/archsurg.139.3.320.CrossRefPubMed Chang CH, Chau GY, Lui WY, Tsay Sh, King KL, Wu CW: Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg. 2004, 139: 320-325. 10.1001/archsurg.139.3.320.CrossRefPubMed
24.
go back to reference Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Chiu JH, Wu CW, P’eng FK: Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs’ A patients. J Surg Oncol. 1997, 66: 122-126. 10.1002/(SICI)1096-9098(199710)66:2<122::AID-JSO9>3.0.CO;2-F.CrossRefPubMed Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Chiu JH, Wu CW, P’eng FK: Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs’ A patients. J Surg Oncol. 1997, 66: 122-126. 10.1002/(SICI)1096-9098(199710)66:2<122::AID-JSO9>3.0.CO;2-F.CrossRefPubMed
25.
go back to reference Takano S, Oishi H, Kono S, Kawakami S, Nakamura M, Kubota N, Iwai S: Retrospective analysis of type of hepatic resection for hepatocellular carcinoma. Br J Surg. 2000, 87: 65-70.CrossRefPubMed Takano S, Oishi H, Kono S, Kawakami S, Nakamura M, Kubota N, Iwai S: Retrospective analysis of type of hepatic resection for hepatocellular carcinoma. Br J Surg. 2000, 87: 65-70.CrossRefPubMed
26.
go back to reference Alkofer B, Lepennec V, Chiche L: Hepatocellular cancer in the non-cirrhotic liver. J Visc Surg. 2011, 148: 3-11. 10.1016/j.jviscsurg.2010.12.012.CrossRefPubMed Alkofer B, Lepennec V, Chiche L: Hepatocellular cancer in the non-cirrhotic liver. J Visc Surg. 2011, 148: 3-11. 10.1016/j.jviscsurg.2010.12.012.CrossRefPubMed
27.
go back to reference Toonen F, Smilde T: A retroperitoneal mass with elevated alpha-1-fetoprotein: not always a testicular carcinoma. Neth J Med. 2010, 68: 33-34.PubMed Toonen F, Smilde T: A retroperitoneal mass with elevated alpha-1-fetoprotein: not always a testicular carcinoma. Neth J Med. 2010, 68: 33-34.PubMed
28.
go back to reference Schmoll HJ, Jordan K, Huddart R, Pes MP, Horwich A, Fizazi K, Kataja V: Testicular seminoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010, 21: 147-154. 10.1093/annonc/mdq177.CrossRef Schmoll HJ, Jordan K, Huddart R, Pes MP, Horwich A, Fizazi K, Kataja V: Testicular seminoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010, 21: 147-154. 10.1093/annonc/mdq177.CrossRef
29.
go back to reference Kanda T, Yoshida H, Mamada Y, Taniai N, Kawano Y, Mizuguchi Y, Shimizu T, Takahashi T, Ueda J, Kato S, Akimaru K, Tajiri T, Fukuda Y: Resection of liver metastases from an alpha-fetoprotein-producing gastric cancer. J Nihon Med Sch. 2005, 72: 66-70. 10.1272/jnms.72.66.CrossRef Kanda T, Yoshida H, Mamada Y, Taniai N, Kawano Y, Mizuguchi Y, Shimizu T, Takahashi T, Ueda J, Kato S, Akimaru K, Tajiri T, Fukuda Y: Resection of liver metastases from an alpha-fetoprotein-producing gastric cancer. J Nihon Med Sch. 2005, 72: 66-70. 10.1272/jnms.72.66.CrossRef
30.
go back to reference Liu CZ, Hu SY, Wang L, Zhi XT, Jin B, Zhu M, Wachtel MS, Frezza EE: Hepatoid carcinoma of the pancreas: a case report. Chin Med J (Engl). 2007, 120: 1850-1852. Liu CZ, Hu SY, Wang L, Zhi XT, Jin B, Zhu M, Wachtel MS, Frezza EE: Hepatoid carcinoma of the pancreas: a case report. Chin Med J (Engl). 2007, 120: 1850-1852.
31.
go back to reference Kitada M, Ozawa K, Sato K, Matsuda Y, Hayashi S, Tokusashi Y, Miyokawa N, Sasajima T: Alpha-fetoprotein-producing primary lung carcinoma: a case report. World J Surg Oncol. 2011, 9: 47-10.1186/1477-7819-9-47.PubMedCentralCrossRefPubMed Kitada M, Ozawa K, Sato K, Matsuda Y, Hayashi S, Tokusashi Y, Miyokawa N, Sasajima T: Alpha-fetoprotein-producing primary lung carcinoma: a case report. World J Surg Oncol. 2011, 9: 47-10.1186/1477-7819-9-47.PubMedCentralCrossRefPubMed
32.
go back to reference Perkins GL, Slater ED, Sanders GK, Prichard JG: Serum tumor markers. Am Fam Physician. 2003, 68: 1075-1082.PubMed Perkins GL, Slater ED, Sanders GK, Prichard JG: Serum tumor markers. Am Fam Physician. 2003, 68: 1075-1082.PubMed
33.
go back to reference Babali A, Cakal E, Purnak T, Biyikoĝlu I, Cakal B, Yüksel O, Köklü S: Serum alpha-fetoprotein levels in liver steatosis. Hepatol Int. 2009, 10.1007/ s12072-009-9156-8. Nov 5 Babali A, Cakal E, Purnak T, Biyikoĝlu I, Cakal B, Yüksel O, Köklü S: Serum alpha-fetoprotein levels in liver steatosis. Hepatol Int. 2009, 10.1007/ s12072-009-9156-8. Nov 5
34.
go back to reference Takuma Y, Nouso K: Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J Gastroenterol. 2010, 16: 1436-1441. 10.3748/wjg.v16.i12.1436.PubMedCentralCrossRefPubMed Takuma Y, Nouso K: Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J Gastroenterol. 2010, 16: 1436-1441. 10.3748/wjg.v16.i12.1436.PubMedCentralCrossRefPubMed
35.
go back to reference Wree A, Kahraman A, Gerken G, Canbay A: Obesity affects the liver - the link between adipocytes and hepatocyte. Digestion. 2011, 83: 124-133. 10.1159/000318741.CrossRefPubMed Wree A, Kahraman A, Gerken G, Canbay A: Obesity affects the liver - the link between adipocytes and hepatocyte. Digestion. 2011, 83: 124-133. 10.1159/000318741.CrossRefPubMed
36.
go back to reference Chagas AL, Kikuchi LO, Oliveira JP, Vezozzo DC, Mello ES, Oliveira AC, Cella LC, Herman P, Bachella T, Caldwell SH, Alves VA, Carrilho FJ: Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?. Braz J Med Biol Res. 2009, 42: 958-962. 10.1590/S0100-879X2009005000019.CrossRefPubMed Chagas AL, Kikuchi LO, Oliveira JP, Vezozzo DC, Mello ES, Oliveira AC, Cella LC, Herman P, Bachella T, Caldwell SH, Alves VA, Carrilho FJ: Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?. Braz J Med Biol Res. 2009, 42: 958-962. 10.1590/S0100-879X2009005000019.CrossRefPubMed
37.
go back to reference Houwert AC, Giltay JC, Lentjes EG, Lock MT: Hereditary persistence of alpha-fetoprotein (HPAFP): review of the literature. Neth J Med. 2010, 68: 354-358.PubMed Houwert AC, Giltay JC, Lentjes EG, Lock MT: Hereditary persistence of alpha-fetoprotein (HPAFP): review of the literature. Neth J Med. 2010, 68: 354-358.PubMed
38.
go back to reference No authors listed: Program of the annual meeting of the American Gastroenterology Association for the Study of Liver Diseases, and the Gastroenterology Study Group. Abstracts of Papers. Gastroenterology. 1979, 76: 1089-1316. No authors listed: Program of the annual meeting of the American Gastroenterology Association for the Study of Liver Diseases, and the Gastroenterology Study Group. Abstracts of Papers. Gastroenterology. 1979, 76: 1089-1316.
Metadata
Title
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature
Authors
Isidoro Di Carlo
Maurizio Mannino
Adriana Toro
Annalisa Ardiri
Antonio Galia
Giovanni Cappello
Gaetano Bertino
Publication date
01-12-2012
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2012
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-79

Other articles of this Issue 1/2012

World Journal of Surgical Oncology 1/2012 Go to the issue